1Cuningham FG, Leveno KJ, Bloom SL, et al. Williams obstetrics. 22st ed. New York:McGraw-Hill, 2005.
2Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P,et al. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis,2010,69: 20-28.
3Bertsias G, Ioannidis JP, Boletis J, et al. EULARrecommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis,2008,67 : 195-205.
4Parke A, West B. Hydroxychloroquine in pregnant patients with systemic lupus erythematosus. J Rheumatol, 1996,23:1715-1718.
5Levy RA, Vilela VS, Cataldo MJ, et al. Hydroxychloroquint (HCQ) in lupus pregnancy: double-blind and placebo-controllet study. Lupus ,2001,10:401-404.
6Clowse ME, Magder L, Witter F, et al. Hydroxychloroquine in lupus pregnancy. Arthritis Rheum, 2006,54:3640-3647.
7Levy M, Buskila D, Gtadman DD, et al. Pregnancy outcome following first trimester exposure to chloroquine. Am J Perinatol, 1991,8 : 174-178.
8Buchanan NM, Toubi E, Khamashta MA, et al. Hydroxychloroquine and lupus pregnancy : review of a series of 36 cases. Ann Rheum Dis, 1996,55:486-488.
9Klinger G, Morad Y, Westall CA, et al. Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases. Lancet,2001,358:813-814.
10Costedoat-Chalumeau N, Amoura Z, Duhaut P, et al. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases : a study of one hundred thirty-three cases compared with a control group. Arthritis Rheum,2003,48:3207-3211.
1Ritchie J, Smyth A, Tower C, et al. Maternal deaths in woman with lupus nephritis.-a review of published evidence[J]. Lu pus, 2012,21 : 534- 541.
2Chabbert- Buffet N, Amoura Z, Scarabin PY, et al. Pregnane progestin contraception in systemic lupus erythematosus., a longitudinal study of 187 patients[J]. Contraception, 2011,83 229-237.
